Augmenting Cerebral Blood Flow to Preserve the Penumbra Trial

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 100 participants.

Also called NCT04014621

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; quadruple masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 100 participants (planned count) (from the registry)
Sponsor
BrainsGate (from the registry)
Registry
  • NCT NCT04014621
Started
(actual) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Georgia (from the registry)
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT04014621. Randomized; quadruple masking; primary purpose treatment. Start 2019-10-20 (actual); primary completion 2021-01 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Augmenting Cerebral Blood Flow to Preserve the Penumbra Trial
Acronym
ImpACT-P
Intervention (Device)
SPG stimulation
Lead sponsor
BrainsGate (class: industry)

Record details

Record id
cardio:ct-nct04014621
Content hash
bd163e87c9fbb9fec9d1e0640d78af0421870a1a335decf92cf2a5063b8bfe6e